Assessing the role of statin therapy in bladder cancer: evidence from a Mendelian Randomization study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Rosuvastatin use may causally decrease bladder cancer risk, according to Mendelian Randomization (MR) analysis. Atorvastatin and simvastatin showed no significant association with bladder cancer risk in this study.
Area Of Science
- Pharmacogenomics
- Oncology
- Epidemiology
Background
- Statins are widely prescribed lipid-lowering drugs for cardiovascular disease prevention.
- Emerging research suggests potential roles for statins in cancer prevention.
- The causal relationship between statin use and bladder cancer remains uncertain.
Purpose Of The Study
- To investigate the potential causal effect of statin therapy on bladder cancer risk.
- To analyze the specific associations of atorvastatin, simvastatin, and rosuvastatin with bladder cancer.
- To leverage Mendelian Randomization (MR) for robust causal inference.
Main Methods
- A two-sample Mendelian Randomization (MR) study design was employed.
- Genetic data from large-scale genome-wide association studies (GWAS) were utilized.
- Summary-level data from UK Biobank (statin use) and a European cohort (bladder cancer) were analyzed.
Main Results
- Rosuvastatin use showed a significant inverse causal association with bladder cancer risk (OR = 3.52E-19, p = 0.005).
- Atorvastatin and simvastatin did not demonstrate a statistically significant causal link with bladder cancer risk.
- Sensitivity analyses were performed to ensure the reliability of the findings.
Conclusions
- Genetically predicted rosuvastatin use is associated with a reduced risk of bladder cancer.
- No significant genetically predicted causal effects were found for atorvastatin or simvastatin on bladder cancer.
- These findings contribute to understanding the complex interplay between statins and cancer risk.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...